A new $7.4 billion settlement with states has been reached with Purdue Pharma and its Sackler family owners. We'll unpack.

Members of the Sackler family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion ...

This story incorporates reporting fromBoston.com, Philadelphia Inquirer, The Boston Globe, pharmaphorum, Hartford Courant, ...

Utah will receive $57 million to combat the state’s opioid crisis if it joins the $7.4 billion settlement against the Sackler ...

The deal comes after the Supreme Court blocked a controversial bankruptcy plan for Purdue that shielded Sackler family ...

In the latest twist in its efforts to wrap up years of high-profile opioid litigation, the billionaire family behind the ...

The settlement is the largest deal to date with the people primarily who played an “instrumental role” in driving the opioid ...

Connecticut and 14 other states on Thursday agreed to a new settlement deal with the Sackler family and Purdue Pharma that ...

Family and company to make payment to group of US states and other parties to settle long-running litigation over OxyContin’s ...

The new settlement reopens a path to ending Purdue’s chapter 11 case, the longest and costliest corporate bankruptcy stemming from the U.S. opioid epidemic.

A settlement reached with the Sackler family and Purdue Pharma will bring over $27 million to the First State, roughly half ...

The Sackler family agreed to give up ownership of the company that manufactures the powerful opioid. A previous deal was ...